Principia Biopharma Inc. (PRNB): Price and Financial Metrics


Principia Biopharma Inc. (PRNB)

Today's Latest Price: $57.83 USD

0.15 (-0.26%)

Updated Apr 7 8:00pm

Add PRNB to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

PRNB Stock Summary

  • PRNB's went public 1.56 years ago, making it older than merely 1.89% of listed US stocks we're tracking.
  • The ratio of debt to operating expenses for Principia Biopharma Inc is higher than it is for about only 0.34% of US stocks.
  • Over the past twelve months, PRNB has reported earnings growth of -1,194%, putting it ahead of just 1.54% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Principia Biopharma Inc are NVAX, BPMC, AGIO, ARWR, and CKPT.
  • PRNB's SEC filings can be seen here. And to visit Principia Biopharma Inc's official web site, go to www.principiabio.com.
PRNB Daily Price Range
PRNB 52-Week Price Range

PRNB Stock Price Chart More Charts


PRNB Price/Volume Stats

Current price $57.83 52-week high $75.65
Prev. close $57.98 52-week low $25.35
Day low $55.76 Volume 414,600
Day high $59.54 Avg. volume 315,469
50-day MA $58.74 Dividend yield N/A
200-day MA $43.95 Market Cap 1.91B

Principia Biopharma Inc. (PRNB) Company Bio


Principia Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on developing novel oral therapies for immunology and oncology in the United States. It is developing PRN1008, an inhibitor that is in Phase II clinical trial for the treatment of pemphigus, a chronic skin disease, as well as in Phase II clinical trial for the treatment of immune thrombocytopenic purpura; PRN2246, an inhibitor that is in Phase I clinical trial for the treatment of multiple sclerosis and other central nervous system diseases; PRN1371, a drug candidate, which is in Phase I clinical trial for the treatment of solid tumors; and oral small molecule inhibitors of the immunoproteasome. The company has collaboration agreements with Genzyme Corporation and AbbVie Biotechnology Limited. Principia Biopharma Inc. was founded in 2008 and is based in South San Francisco, California.


PRNB Latest News Stream


Event/TimeNews Detail
Loading, please wait...

PRNB Latest Social Stream


Loading social stream, please wait...

View Full PRNB Social Stream

PRNB Price Returns

1-mo -1.88%
3-mo 12.23%
6-mo 97.71%
1-year 89.42%
3-year N/A
5-year N/A
YTD 5.57%
2019 100.00%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Continue Researching PRNB

Here are a few links from around the web to help you further your research on Principia Biopharma Inc's stock as an investment opportunity:

Principia Biopharma Inc (PRNB) Stock Price | Nasdaq
Principia Biopharma Inc (PRNB) Stock Quote, History and News - Yahoo Finance
Principia Biopharma Inc (PRNB) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7543 seconds.